These data not only reveal that autocrine CXCR-2 signaling pathway activation in GBM cells is involved in the latter paracrine activation of stromal fibroblasts but also the direct activation of CXCR-2 signaling in fibroblasts is essential to regulate their functional properties. The gene discussed is CXCR2; the disease is glioblastoma.